---
schema_version: "secwatch.filing_event.v1"
accession: "0001185185-23-000961"
form_type: "8-K"
ticker: "STEX"
cik: "0001530766"
company_name: "Streamex Corp."
filed_at: "2023-09-12T23:59:59+00:00"
generated_at: "2026-06-10T20:59:40.302159+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# BioSig receives Nasdaq delisting notice for bid price under $1.00

## Summary
- Nasdaq letter dated Sept 6, 2023: closing bid price below $1.00 for 30 consecutive business days.
- Company has 180-day compliance period until March 4, 2024 to regain minimum bid price requirement.
- To cure, common stock must close at $1.00 for at least ten consecutive business days.
- If not cured, may qualify for second 180-day period by meeting other listing standards and planning reverse stock split.
- No immediate effect on trading; shares continue listing on Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001185185-23-000961
- form_type: 8-K
- ticker: STEX
- cik: 0001530766
- company_name: Streamex Corp.
- filed_at: 2023-09-12T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1530766/000118518523000961/0001185185-23-000961-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1530766/000118518523000961/biosig20230906_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001185185-23-000961
- JSON: https://secwatch.observer/filing/0001185185-23-000961.json
- Plain text: https://secwatch.observer/filing/0001185185-23-000961.txt

## Key facts
- Listing & Compliance Notices
  Streamex Corp. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: September 6, 2023, BioSig Technologies, Inc. (the “Company”) received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock for the 30 consecutive business days between July 25, 2023, to September 5, 2023, the Company did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2). The letter also indicated that the Company will be provided with a compliance period of 180 calendar days, o
  evidence_url: https://www.sec.gov/Archives/edgar/data/1530766/000118518523000961/0001185185-23-000961-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.